{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T16:51:24Z","timestamp":1743094284301,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":15,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071625644"},{"type":"electronic","value":"9781071625651"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-1-0716-2565-1_38","type":"book-chapter","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T21:02:45Z","timestamp":1663707765000},"page":"431-437","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Quantitation of Pyrimidine in Urine by Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry"],"prefix":"10.1007","author":[{"given":"Ning","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,21]]},"reference":[{"key":"38_CR1","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/0006-2952(96)00035-4","volume":"51","author":"GW Aherne","year":"1996","unstructured":"Aherne GW, Hardcastle A, Raynaud F et al (1996) Immunoreactive dUMP and TTP pools as an index of thymidylate synthase inhibition; effect of tomudex (ZD1694) and a nonpolyglutamated quinazoline antifolate (CB30900) in L1210 mouse leukaemia cells. Biochem Pharmacol 51:1293\u20131301","journal-title":"Biochem Pharmacol"},{"key":"38_CR2","doi-asserted-by":"crossref","unstructured":"Andre Bp Van Kuilenburg AVC, Nico Ggm Aberling (ed) (2008) Screening for disorders of purine and pyrimidine metabolism using HPLC-electrospray tandem mass spectrometry. Springer-Verlag, Berlin Heidelberg","DOI":"10.1007\/978-3-540-76698-8_31"},{"key":"38_CR3","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s10545-014-9742-3","volume":"37","author":"S Balasubramaniam","year":"2014","unstructured":"Balasubramaniam S, Duley JA, Christodoulou J (2014) Inborn errors of pyrimidine metabolism: clinical update and therapy. J Inherit Metab Dis 37:687\u2013698","journal-title":"J Inherit Metab Dis"},{"volume-title":"Spectral data and pK values for purines, pyrimidines, nucleosides, and nucleotides","year":"1974","key":"38_CR4","unstructured":"Burton K (ed) (1974) Spectral data and pK values for purines, pyrimidines, nucleosides, and nucleotides. Oxford University Press, London"},{"volume-title":"Disorders of purine and pyrimidine metabolism","year":"2012","key":"38_CR5","unstructured":"Georges Van Den Berghe M-FV, Marie S (eds) (2012) Disorders of purine and pyrimidine metabolism. Springer-Verlag, Berlin Heidelberg"},{"key":"38_CR6","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrd4010","volume":"12","author":"LP Jordheim","year":"2013","unstructured":"Jordheim LP, Durantel D, Zoulim F et al (2013) Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases. Nat Rev Drug Discov 12:447\u2013464","journal-title":"Nat Rev Drug Discov"},{"key":"38_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10545-009-1094-z","volume":"32","author":"A Jurecka","year":"2009","unstructured":"Jurecka A (2009) Inborn errors of purine and pyrimidine metabolism. J Inherit Metab Dis 32:247\u2013263","journal-title":"J Inherit Metab Dis"},{"key":"38_CR8","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/B978-0-7020-4087-0.00055-3","volume":"120","author":"RE Kelley","year":"2014","unstructured":"Kelley RE, Andersson HC (2014) Disorders of purines and pyrimidines. Handb Clin Neurol 120:827\u2013838","journal-title":"Handb Clin Neurol"},{"key":"38_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40170-020-00218-5","volume":"8","author":"T Mollick","year":"2020","unstructured":"Mollick T, La\u00edn S (2020) Modulating pyrimidine ribonucleotide levels for the treatment of cancer. Cancer Metab 8:12","journal-title":"Cancer Metab"},{"key":"38_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ymgme.2005.07.027","volume":"86","author":"WL Nyhan","year":"2005","unstructured":"Nyhan WL (2005) Disorders of purine and pyrimidine metabolism. Mol Genet Metab 86:25\u201333","journal-title":"Mol Genet Metab"},{"key":"38_CR11","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1248\/cpb.44.1252","volume":"44","author":"T Ohyama","year":"1996","unstructured":"Ohyama T, Matsubara C, Takamura K (1996) Highly sensitive densitometry for Sugarphosphoeters and nucleotides using enzymatic hydrolysis on TLC plate. Chem Pharm Bull 44:1252\u20131254","journal-title":"Chem Pharm Bull"},{"key":"38_CR12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/gim.2013.32","volume":"15","author":"GB Schaefer","year":"2013","unstructured":"Schaefer GB, Mendelsohn NJ (2013) Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions. Genet Med 15:399\u2013407","journal-title":"Genet Med"},{"volume-title":"Inborn error of purine and pyrimidine metabolism","year":"2006","key":"38_CR13","unstructured":"Van Gennip Ah BH, WI N (eds) (2006) Inborn error of purine and pyrimidine metabolism. Springer-Verlag, Berlin, Heidelberg"},{"key":"38_CR14","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.bbadis.2010.03.013","volume":"1802","author":"AB Van Kuilenburg","year":"2010","unstructured":"Van Kuilenburg AB, Dobritzsch D, Meijer J et al (2010) Dihydropyrimidinase deficiency: phenotype, genotype and structural consequences in 17 patients. Biochim Biophys Acta 1802:639\u2013648","journal-title":"Biochim Biophys Acta"},{"key":"38_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ymgme.2007.02.008","volume":"91","author":"AB Van Kuilenburg","year":"2007","unstructured":"Van Kuilenburg AB, Meijer J, Dobritzsch D et al (2007) Clinical, biochemical and genetic findings in two siblings with a dihydropyrimidinase deficiency. Mol Genet Metab 91:157\u2013164","journal-title":"Mol Genet Metab"}],"container-title":["Methods in Molecular Biology","Clinical Applications of Mass Spectrometry in Biomolecular Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2565-1_38","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T21:05:38Z","timestamp":1663707938000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2565-1_38"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9781071625644","9781071625651"],"references-count":15,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2565-1_38","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"21 September 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}